Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Clinical Pharmacokinetics of Cyclophosphamide
2005 • 412 citations
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells
1996 • 370 citations
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
1999 • 337 citations
Real-Time Quantitative PCR Assays for Detection andMonitoring of Pathogenic Human Viruses in ImmunosuppressedPediatricPatients
2004 • 317 citations
Viral gene therapy strategies: from basic science to clinical application
2005 • 312 citations
Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911
2006 • 285 citations
The E3-11.6-kDa Adenovirus Death Protein (ADP) Is Required for Efficient Cell Death: Characterization of Cells Infected withadpMutants
1996 • 223 citations
FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS
2004 • 190 citations
Syrian Hamster as a Permissive Immunocompetent Animal Model for the Study of Oncolytic Adenovirus Vectors
2006 • 163 citations
Cyclophosphamide Diminishes Inflammation and Prolongs Transgene Expression Following Delivery of Adenoviral Vectors to Mouse Liver and Lung
1996 • 161 citations
Complement Depletion Facilitates the Infection of Multiple Brain Tumors by an Intravascular, Replication-Conditional Herpes Simplex Virus Mutant
2000 • 151 citations
Immune Reconstitution and Clearance of Human Adenovirus Viremia in Pediatric Stem‐Cell Recipients
2005 • 141 citations
Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation
2005 • 136 citations
Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector.
1996 • 127 citations
Oncolytic viral therapies
2004 • 126 citations
Tolerance induction in clinical transplantation
2004 • 122 citations
Intratumoral Spread of Wild-Type Adenovirus Is Limited After Local Injection of Human Xenograft Tumors: Virus Persists and Spreads Systemically at Late Time Points
2003 • 122 citations
Overexpression of the ADP (E3-11.6K) Protein Increases Cell Lysis and Spread of Adenovirus
2003 • 121 citations
Adenovirus Methods and Protocols
2007 • 115 citations
Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity
2005 • 107 citations
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer
2006 • 102 citations
Wild-Type Adenovirus Decreases Tumor Xenograft Growth, but Despite Viral Persistence Complete Tumor Responses Are Rarely Achieved—Deletion of the Viral E1b-19-kD Gene Increases the Viral Oncolytic Effect
2001 • 97 citations
Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector Vaccines
2004 • 83 citations
Effect of Adenovirus-Mediated Heat Shock Protein Expression and Oncolysis in Combination with Low-Dose Cyclophosphamide Treatment on Antitumor Immune Responses
2006 • 82 citations
Busulfan-cyclophosphamide versus total body irradiation–cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: What have we learned?
2003 • 78 citations
Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission
2004 • 78 citations
Prostate Cancer Gene Therapy Clinical Trials
2007 • 74 citations
Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide
1998 • 71 citations
Cyclophosphamide Allows for In vivo Dose Reduction of a Potent Oncolytic Virus
2005 • 69 citations
Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects
2005 • 66 citations
Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
1996 • 61 citations
Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity
2005 • 57 citations
Use of the Syrian Hamster as an Animal Model for Oncolytic Adenovirus Vectors
2007 • 52 citations
An Oncolytic Adenovirus Vector Combining Enhanced Cell-to-Cell Spreading, Mediated by the ADP Cytolytic Protein, with Selective Replication in Cancer Cells with Deregulated Wnt Signaling
2004 • 52 citations
Efficacy of Severe Acute Respiratory Syndrome Vaccine Based on a Nonhuman Primate Adenovirus in the Presence of Immunity Against Human Adenovirus
2006 • 51 citations
Immunosuppression promotes reovirus therapy of colorectal liver metastases
2006 • 48 citations
Adenoviral Strategies for the Gene Therapy of Cancer
2005 • 34 citations
Oncolytic adenoviruses as antiglioma agents
2006 • 28 citations
Immune Transfer Protects Severely Immunosuppressed Mice from Murine Cytomegalovirus Retinitis and Reduces the Viral Load in Ocular Tissue
2000 • 21 citations
Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines
1990 • 18 citations
Studies of pulmonary and renal immunopathology after nonlethal primary sendai viral infection in normal and cyclophosphamide-treated hamsters.
1977 • 13 citations
Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high‐dose cyclophosphamide: a retrospective review of 141 patients
2005 • 7 citations
Reduced-intensity transplantation for lymphoma
2006 • 4 citations
Tolerability and safety of classic cyclophosphamide, methotrexate, and fluorouracil treatment in japanese patients with early Breast Cancer
2006 • 4 citations